Related references
Note: Only part of the references are listed.Simultaneous Analysis of Multiple Monoclonal Antibody Biotherapeutics by LC-MS/MS Method in Rat Plasma Following Cassette-Dosing
Hongyan Li et al.
AAPS JOURNAL (2013)
Fully Validated LC-MS/MS Assay for the Simultaneous Quantitation of Coadministered Therapeutic Antibodies in Cynomolgus Monkey Serum
Hao Jiang et al.
ANALYTICAL CHEMISTRY (2013)
Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: Practical considerations in assay development and validation
Guowen Liu et al.
JOURNAL OF CHROMATOGRAPHY A (2013)
Development of a validated liquid chromatography tandem mass spectrometry assay for a PEGylated adnectin in cynomolgus monkey plasma using protein precipitation and trypsin digestion
Michelle L. Dawes et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Bioanalytical LC-MS/MS of protein-based biopharmaceuticals
Irene van den Broek et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies
Shujie J. Wang et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
General LC-MS/MS Method Approach to Quantify Therapeutic Monoclonal Antibodies Using a Common Whole Antibody Internal Standard with Application to Preclinical Studies
Hongyan Li et al.
ANALYTICAL CHEMISTRY (2012)
Clinical Pharmacokinetic Assessment of an Anti-MAdCAM Monoclonal Antibody Therapeutic by LC-MS/MS
Mireia Fernandez Ocana et al.
ANALYTICAL CHEMISTRY (2012)
A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection
Steven T. Wu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS
Matthew Ewles et al.
BIOANALYSIS (2011)
Identification and inhibition of drug target interference in immunogenicity assays
Zhandong D. Zhong et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Delivery of Therapeutic Proteins
Dipak S. Pisal et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients
Heather A. Myler et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Determination of Taspoglutide in Human and Animal Plasma Using Liquid Chromatography-Tandem Mass Spectrometry with Orthogonal Column-Switching
Katja Heinig et al.
ANALYTICAL CHEMISTRY (2009)
Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Absolute quantification of monoclonal antibodies in biofluids by liquid chromatography-tandem mass spectrometry
Charlotte Hagman et al.
ANALYTICAL CHEMISTRY (2008)
Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore
Denise Sickert et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins
Jean Lee et al.
AAPS JOURNAL (2007)
Quantification of small therapeutic proteins in plasma by liquid chromatography - Tandem mass spectrometry: Application to an elastase inhibitor EPI-hNE4
F Becher et al.
ANALYTICAL CHEMISTRY (2006)
An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen
A Patton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis
M Hebbar et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Evaluation of the bioequivalence of highly-variable drugs and drug products
L Tothfalusi et al.
PHARMACEUTICAL RESEARCH (2001)
The roles of CD28 and CD40 ligand in T cell activation and tolerance
KC Howland et al.
JOURNAL OF IMMUNOLOGY (2000)